Publication:
A new bronchodilator response grading strategy ıdentifies distinct patient populations

dc.contributor.authorHansen, James E.
dc.contributor.authorPorszasz, Janos
dc.contributor.authorStringer, William W.
dc.contributor.authorPak, Youngju
dc.contributor.authorRossiter, Harry B.
dc.contributor.authorCasaburi, Richard
dc.contributor.buuauthorDilektaşlı, Aslı G.
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentDahili Tıp Bilimleri
dc.contributor.departmentGöğüs Hastalıkları Bölümü
dc.contributor.orcid0000-0001-7099-9647
dc.contributor.scopusid36466376600
dc.date.accessioned2023-06-15T13:34:42Z
dc.date.available2023-06-15T13:34:42Z
dc.date.issued2019-12
dc.description.abstractRationale: A positive bronchodilator response (BDR) according to American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines require both 200 ml and 12% increase in forced expiratory volume in 1 second (FEV1) or forced vital capacity (FVC) after bronchodilator inhalation. This dual criterion is insensitive in those with high or low FEV1. Objectives: To establish BDR criteria with volume or percentage FEV1 change. Methods: The largest FEV1 and FVC were identified fromthree pre- and three post-bronchodilator maneuvers in COPDGene (Genetic Epidemiology of COPD) participants. A total of 7,741 individuals with coefficient of variation less than 15% for both FEV1 and FVC formed bronchodilator categories of FEV1 response: negative (<= 0.00% or <= 0.00 L), minimal (>0.00% to <= 9.00% or >0.00 L to <= 0.09 L), mild (>9.00% to <= 16.00% or.0.09 L to <0.16 L), moderate (>16.00% to <= 26.00% or >0.16 L to <= 0.26 L), and marked (>26.00% or >0.26 L). These response size categories are based on empirical limits considering average FEV1 increase of approximately 160 ml and the clinically important difference for FEV1. To compare flow and volume response characteristics, BDR-FEV1 category assignments were applied for the BDR-FVC response. Results: Twenty percent met mild and 31% met moderate or marked BDR-FEV1 criteria, whereas 12% met mild and 33% met moderate or marked BDR-FVC criteria. In contrast, only 20.6% met ATS/ERS positive criteria. Compared with the negative BDR-FEV1 category, the minimal, mild, moderate, and marked BDR-FEV1 categories were associated with greater 6-minute-walk distance and lower St. George's Respiratory Questionnaire and modified Medical Research Council dyspnea scale scores. Compared with negative BDR, moderate and marked BDR-FEV1 categories were associated with fewer exacerbations, and minimal BDR was associated with lower computed tomography airway wall thickness. Compared with the negative category, all BDR-FVC categories were associated with increasing emphysema percentage and gas trapping percentage. Moderate and marked BDR-FVC categories were associated with higher St. George's Respiratory Questionnaire scores but fewer exacerbations and lower dyspnea scores. Conclusions: BDR grading by FEV1 volume or percentage response identified subjects otherwise missed by ATS/ERS criteria. BDR grades were associated with functional exercise performance, quality of life, exacerbation frequency, dyspnea, and radiological airway measures. BDR grades in FEV1 and FVC indicate different clinical and radiological characteristics.
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Heart Lung & Blood Institute (NHLBI)
dc.description.sponsorshipNational Center for Advancing Translational Sciences through UCLA CTSI Grant
dc.identifier.citationHansen, J. E. vd. (2019). ''A new bronchodilator response grading strategy ıdentifies distinct patient populations''. Annals of the American Thoracic Society, 16(12), 1504-1517.
dc.identifier.endpage1517
dc.identifier.issn1546-3222
dc.identifier.issn2325-6621
dc.identifier.issue12
dc.identifier.pubmed31404502
dc.identifier.scopus2-s2.0-85075774981
dc.identifier.startpage1504
dc.identifier.urihttps://doi.org/10.1513/AnnalsATS.201901-030OC
dc.identifier.urihttps://www.atsjournals.org/doi/10.1513/AnnalsATS.201901-030OC
dc.identifier.urihttp://hdl.handle.net/11452/33051
dc.identifier.volume16
dc.identifier.wos000499727700010
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherAmer Thoracic
dc.relation.collaborationYurt dışı
dc.relation.collaborationSanayi
dc.relation.journalAnnals of the American Thoracic Society
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAirflow obstruction
dc.subjectRespiratory System
dc.subjectBronchodilator responsiveness
dc.subjectForced expiratory volume in 1 second
dc.subjectComputed-tomography
dc.subjectAirway-obstruction
dc.subjectOverlap syndrome
dc.subjectReversibility
dc.subjectResponsiveness
dc.subjectCopd
dc.subjectFvc
dc.subjectFev1
dc.subjectVariability
dc.subjectDiagnosis
dc.subject.emtreeBeta 2 adrenergic receptor stimulating agent
dc.subject.emtreeSalbutamol
dc.subject.emtreeBronchodilating agent
dc.subject.emtreeAdult
dc.subject.emtreeAirway obstruction
dc.subject.emtreeAirway remodeling
dc.subject.emtreeAmerican Thoracic Society European Respiratory Society criteria
dc.subject.emtreeArticle
dc.subject.emtreeBronchodilator response grading strategy
dc.subject.emtreeChronic obstructive lung disease
dc.subject.emtreeCohort analysis
dc.subject.emtreeComparative study
dc.subject.emtreeComputer assisted tomography
dc.subject.emtreeControlled study
dc.subject.emtreeCurrent smoker
dc.subject.emtreeDisease exacerbation
dc.subject.emtreeDyspnea
dc.subject.emtreeEx-smoker
dc.subject.emtreeExercise
dc.subject.emtreeFemale
dc.subject.emtreeForced expiratory volume
dc.subject.emtreeForced vital capacity
dc.subject.emtreeFunctional status
dc.subject.emtreeHuman
dc.subject.emtreeLung emphysema
dc.subject.emtreeLung volume
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMiddle aged
dc.subject.emtreeModified medical research council dyspnea scale
dc.subject.emtreeMorbidity
dc.subject.emtreePractice guideline
dc.subject.emtreeQuality of life
dc.subject.emtreeRespiratory tract disease assessment
dc.subject.emtreeSix minute walk test
dc.subject.emtreeSt. George respiratory questionnaire
dc.subject.emtreeAged
dc.subject.emtreeChronic obstructive lung disease
dc.subject.emtreeClinical trial
dc.subject.emtreeForced expiratory volume
dc.subject.emtreeLung function test
dc.subject.emtreeMulticenter study
dc.subject.emtreePathophysiology
dc.subject.emtreeQuestionnaire
dc.subject.emtreeSeverity of illness index
dc.subject.emtreeSpirometry
dc.subject.emtreeStatistical model
dc.subject.emtreeVital capacity
dc.subject.emtreeX-ray computed tomography
dc.subject.meshAged
dc.subject.meshBronchodilator agents
dc.subject.meshFemale
dc.subject.meshForced expiratory volume
dc.subject.meshHumans
dc.subject.meshLinear models
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshPulmonary disease, chronic obstructive
dc.subject.meshQuality of life
dc.subject.meshRespiratory function tests
dc.subject.meshSeverity of illness index
dc.subject.meshSpirometry
dc.subject.meshSurveys and questionnaires
dc.subject.meshTomography, X-Ray computed
dc.subject.meshVital capacity
dc.subject.scopusUndifferentiated Connective Tissue Diseases; Adrenal Cortex Hormone; Global Initiatives
dc.subject.wosRespiratory system
dc.titleA new bronchodilator response grading strategy ıdentifies distinct patient populations
dc.typeArticle
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Dahili Tıp Bilimleri/Göğüs Hastalıkları Bölümü
local.indexed.atPubMed
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dilektaşlı_vd_2019.pdf
Size:
958.48 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: